Garberg P[au] - Search Results

Year	Number of Results
1987	1
1988	3
1991	1
1992	3
1996	1
1998	2
1999	2
2001	1
2004	3
2005	2
2006	2
2007	1
2022	0

1

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

Baranczewski P, Stańczak A, Sundberg K, Svensson R, Wallin A, Jansson J, Garberg P, Postlind H. Baranczewski P, et al. Among authors: garberg p. Pharmacol Rep. 2006 Jul-Aug;58(4):453-72. Pharmacol Rep. 2006. PMID: 16963792 Free article. Review.

2

Research perspectives for pre-screening alternatives to animal experimentation: on the relevance of cytotoxicity measurements, barrier passage determinations and high throughput screening in vitro to select potentially hazardous compounds in large sets of chemicals.

Walum E, Hedander J, Garberg P. Walum E, et al. Among authors: garberg p. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):393-7. doi: 10.1016/j.taap.2005.01.056. Toxicol Appl Pharmacol. 2005. PMID: 15982691 Review.

3

Blood-brain barrier in vitro models and their application in toxicology. The report and recommendations of ECVAM Workshop 49.

Prieto P, Blaauboer BJ, de Boer AG, Boveri M, Cecchelli R, Clemedson C, Coecke S, Forsby A, Galla HJ, Garberg P, Greenwood J, Price A, Tähti H; European Centre for the Validation of Alternative Methods. Prieto P, et al. Among authors: garberg p. Altern Lab Anim. 2004 Mar;32(1):37-50. doi: 10.1177/026119290403200107. Altern Lab Anim. 2004. PMID: 15603552 Review. No abstract available.

4

Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells.

Celius T, Garberg P, Lundgren B. Celius T, et al. Among authors: garberg p. Biochem Biophys Res Commun. 2004 Nov 5;324(1):365-71. doi: 10.1016/j.bbrc.2004.09.061. Biochem Biophys Res Commun. 2004. PMID: 15465028

5

In vitro models for the blood-brain barrier.

Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO, Osterberg T. Garberg P, et al. Toxicol In Vitro. 2005 Apr;19(3):299-334. doi: 10.1016/j.tiv.2004.06.011. Toxicol In Vitro. 2005. PMID: 15713540

6

Recovery of malondialdehyde in urine as a 2,4-dinitrophenylhydrazine derivative analyzed with high-performance liquid chromatography.

Ekström T, Garberg P, Egestad B, Högberg J. Ekström T, et al. Among authors: garberg p. Chem Biol Interact. 1988;66(3-4):177-87. doi: 10.1016/0009-2797(88)90070-1. Chem Biol Interact. 1988. PMID: 3396120

7

Changes in liver fatty acid-binding protein in rat enzyme-altered foci.

Thullberg M, Grasl-Kraupp B, Högberg J, Garberg P. Thullberg M, et al. Among authors: garberg p. Cancer Lett. 1998 Jun 5;128(1):1-10. doi: 10.1016/s0304-3835(98)00040-8. Cancer Lett. 1998. PMID: 9652787

8

Studies on Se incorporation in selenoproteins; effects of peroxisome proliferators and hydrogen peroxide generating system.

Garberg P, Högberg J. Garberg P, et al. Chem Biol Interact. 1992 Feb;81(3):291-306. doi: 10.1016/0009-2797(92)90083-w. Chem Biol Interact. 1992. PMID: 1540996

9

The role of hypoxia in selenium metabolism.

Garberg P, Högberg J. Garberg P, et al. Biochem Pharmacol. 1987 Apr 15;36(8):1377-9. doi: 10.1016/0006-2952(87)90098-0. Biochem Pharmacol. 1987. PMID: 3593424 No abstract available.

10

Binding of tellurium to hepatocellular selenoproteins during incubation with inorganic tellurite: consequences for the activity of selenium-dependent glutathione peroxidase.

Garberg P, Engman L, Tolmachev V, Lundqvist H, Gerdes RG, Cotgreave IA. Garberg P, et al. Int J Biochem Cell Biol. 1999 Feb;31(2):291-301. doi: 10.1016/s1357-2725(98)00113-7. Int J Biochem Cell Biol. 1999. PMID: 10216961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results